Study on health efficacy and mechanism of oral postbiotics

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500107127

Enrollment

Unknown

Registered

2025-08-04

Start date

2025-08-06

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic floor dysfunction, ovarian dysfunction, skin aging

Interventions

Group A:Placebo

Group B:Postbiotics

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pelvic floor dysfunction, ovarian dysfunction, and skin aging.

Exclusion criteria

Exclusion criteria: Exclude subjects with severe uterine fibroids;adenomyosis;endometriosis;heart, liver or kidney diseases; autoimmune diseases; malignant tumors or recent use of steroid drugs or probiotic products.

Design outcomes

Primary

Measure	Time frame
Pelvic floor function improved;Ovarian function;Improve skin condition;	—

Secondary

Measure	Time frame
Liver and kidney function;	—

Countries

China

Contacts

Public ContactQinghong Ji

The Second Hospital of Shandong University

jqh0117@126.com+86 531 85875762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026